Duration of untreated psychosis: A proposition regarding treatment definition

Early Intervention in Psychiatry

Volumn 5, Issue 4, 2011, Pages 301-308

  Polari, Andrea ^a,b,c   Lavoie, Suzie ^b,d   Sarrasin, Pascale ^a   Pellanda, Veronica ^a,b   Cotton, Sue ^d   Conus, Philippe ^a  

^a Treatment and Early Intervention in Psychosis Program (TIPP)   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Duration of untreated psychosis; First episode psychosis; Treatment

Indexed keywords

CANNABIS; NEUROLEPTIC AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; DURATION OF UNTREATED PSYCHOSIS; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; SCORING SYSTEM; SOCIAL INTERACTION; TREATMENT DURATION; TREATMENT FAILURE;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80055056521     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2011.00308.x     Document Type: Article

References (58)

1. McGorry PD. Evaluating the importance of reducing the duration of untreated psychosis. Aust N Z J Psychiatry 2000; 34 (Suppl.): S145-9.
2. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-83.
3. Clarke M, Whitty P, Browne S etal. Untreated illness and outcome of psychosis. Br J Psychiatry 2006; 189: 235-40.
4. Melle I, Larsen TK, Haahr U etal. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004; 61: 143-50.
5. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804.
6. Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD, Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res 2008; 42: 982-90.
7. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157: 60-6.
8. Goldberg TE, Burdick KE, McCormack J etal. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophr Res 2009; 107: 262-6.
9. Ho BC, Andreasen NC. Long delays in seeking treatment for schizophrenia. Lancet 2001; 357: 898-900.
10. Malla A, Schmitz N, Norman R etal. A multisite Canadian study of outcome of first-episode psychosis treated in publicly funded early intervention services. Can J Psychiatry 2007; 52: 563-71.
11. Singh SP, Cooper JE, Fisher HL etal. Determining the chronology and components of psychosis onset: the Nottingham Onset Schedule (NOS). Schizophr Res 2005; 80: 117-30.
12. Yung AR, Yuen HP, McGorry PD etal. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 2005; 39: 964-71.
13. International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry 2005; 187: s120-s4.
14. Lambert M, Conus P, Lambert T, McGorry PD. Pharmacotherapy of first-episode psychosis. Expert Opin Pharmacother 2003; 4: 717-50.
15. NEPP TNEPP. Australian Guidelines for Early Psychosis. Melbourne: University of Melbourne, 1998.
16. Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177: 207-11.
17. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176: 173-6.
18. Haas GL, Garratt LS, Sweeney JA. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998; 32: 151-9.
19. Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 1996; 153: 519-25.
20. Tirupati NS, Rangaswamy T, Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust N Z J Psychiatry 2004; 38: 339-43.
21. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophr Bull 1998; 24: 75-85.
22. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull 1996; 22: 241-56.
23. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004; 34: 277-84.
24. Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993; 162: 80-6.
25. Kalla O, Aaltonen J, Wahlsrtoem J, Lethinen V, Garcia Cabeza I, Gonzales de Chavez M. Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. Acta Psychiatr Scand 2002; 106: 265-75.
26. Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand 1999; 100: 96-104.
27. Polari A, Berk M, MacNeil C, Conus P. Duration of untreated psychosis: what are we talking about? Acta Neuropsychiatr 2009; 3: 106-8.
28. Garety PA, Craig TK, Dunn G etal. Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br J Psychiatry 2006; 188: 37-45.
29. Petersen L, Jeppesen P, Thorup A etal. A randomized multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005; 331: 602.
30. Conus P, Montagrin Y, Bircher R, Sarasin P, Polari A, Bonsack C. TIPP-Lausanne first episode psychosis program: patient's baseline characteristics and impact of the program on adherence to psychosocial treatment. Schizophr Res 2008; 98: 81-2.
31. Turner M, Smith-Hamel C, Mulder R. Pathways to care in a New Zealand first-episode of psychosis cohort. Aust N Z J Psychiatry 2006; 40: 421-8.
32. Conus P, Polari A, Bonsack C. Intervention dans la phase précoce des troubles psychotiques: objectifs et organisation du programme TIPP (Traitement et intervention dans la phase précoce des troubles psychotiques) à Lausanne. Inf Psychiatr 2010; 86: 145-51.
33. Lambert M, Conus P, Cotton S, Robinson J, McGorry PD, Schimmelmann BG. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. J Clin Psychopharmacol 2010; 30: 565-72.
34. Conus P, Bonsack C. Early intervention for the initial phase of psychotic disorders in Lausanne: what problems and what solutions?. Rev Med Suisse Romande 2004; 124: 221-4.
35. Bonsack C, Adam L, Haefliger T, Besson J, Conus P. Difficult-to-engage patients: a specific target for time-limited assertive outreach in a Swiss setting. Can J Psychiatry 2005; 50: 845-50.
36. Bonsack C, Haefliger T, Cordier S, Conus P. Access to care and maintenance in the community of persons who are difficult to engage in psychiatric treatment. Rev Med Suisse Romande 2004; 124: 225-9.
37. Conus P, Bonsack C, Gommeret E, Philippoz R. Intensive Psychiatric Support at the Setting in Lausanne: a pilot project. Rev Med Suisse Romande 2001; 121: 475-81.
38. APA APA. Diagnostic Criteria from DSM-IV. Washington, DC: American Psychiatric Publishing, 1994.
39. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982; 8: 470-84.
40. Chandola T, Jenkinson C. The new UK National Statistics Socio-Economic Classification (NS-SEC); investigating social class differences in self-reported health status. J Public Health Med 2000; 22: 182-90.
41. Guy W. Clinical Global Impression. Rockville, MI: Department of Health, Education and Welfare, 1976.
42. APA. Diagnostic and Statistical Manual for Mental Disorders, 4th edn. Text Revision (DSM IV-TR). Washington, DC: American Psychiatric Publishing, 2000.
43. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990; 16: 57-67.
44. Keck PE Jr, McElroy SL, Strakowski SM etal. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998; 155: 646-52.
45. Sheehan DV, Lecrubier Y, Sheehan KH etal. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20): 22-33, quiz 4-57.
46. McGorry PD. The influence of illness duration on syndrome clarity and stability in functional psychosis: does the diagnosis emerge and stabilise with time? Aust N Z J Psychiatry 1994; 28: 607-19.
47. Tabachnick B, Fidell L. Using Multivariate Statistics, 5th edn. Boston: Pearson, 2007.
48. Hinkle D, Wiersman W, Jurs S. Applied Statistics for the Behavioural Science. Boston: Houghton Mifflin, 1988.
49. Conus P, Cotton S, Schimmelmann BG, McGorry P, Lambert M. The First-Episode Psychosis Outcome Study: premorbid and baseline characteristics of an epidemiological cohort of 661 first-episode psychosis patients. Early Interv Psychiatry. 2007; 1: 191-200.
50. Bonsack C, Pfister T, Conus P. Linkage to care after first hospitalisation for psychosis. Encephale 2006; 32: 679-85.
51. Lambert M, Conus P, Cotton S, Robinson J, McGorry P, Schimmelmann B. Prevalence, predictors, and outcome of long-term antipsychotic medication refusal in first episode psychosis. J Clin Psychopharmacol 2010; 30: 565-72.
52. de Haan D, Linszen D, Lenior M, De Win E, Gorsira R. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr Bull 2003; 29: 341-8.
53. Rabinovitch M, Bechard-Evans L, Schmitz N, Joober R, Malla A. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry 2009; 54: 28-35.
54. Harrigan S, McGorry P, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003; 33: 97-110.
55. Simonsen E, Friis S, Haahr U etal. Clinical epidemiologic first-episode psychosis 1-year outcome and predictors. Acta Psychiatr Scand 2007; 116: 54-61.
56. Peralta V, Cuesta MJ, Martinez-Larrea A, Serrano JF, Langarica M. Duration of untreated psychotic illness: the role of premorbid social support networks. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 345-9.
57. Pelosi AJ, Birchwood M. Is early intervention for psychosis a waste of valuable resources? Br J Psychiatry 2003; 182: 196-8.
58. Singh SP. Early intervention in psychosis. Br J Psychiatry 2010; 196: 343-5.